Investor Presentation
Company Overview
Significant Barriers to Entry
First mover advantage, comprehensive patent protection and strong product pipeline provide
significant barriers to entry for 4DMedical's target market using XV technology
•
First mover advantage
First mover advantage allows for 4DMedical to deploy further
products across the XV Technology platform to defend market
position and differentiate from future competition
Comprehensive patent protection
• In-house patent attorney
Ten patent families with filings made in eight, for a total of 43 patents
with 15 granted
•
Patents covering:
XV Technology (core patent) |
Heart Imaging
Low Dose Scan
Pulmonary Vascular Imaging | Novel implementation of motion
Clinical Validation
• 70+ peer reviewed publications across extensive network of
KOL research partners
•
Clinical trials and regulatory clearance
Future product pipeline
•
.
Future product suite targeting additional respiratory indications
expected to provide 'whole of market' solution
Ability to deploy further incremental functionality to existing
products at minimal costs allows for additional enhancements
to be deployed quickly and efficiently
measurements
Pg 19 | Investor presentation
PATENT STREAMS
4DMedical
GLOBAL EXCLUSIVE LICENSE
AGREEMENT SIGNED WITH
MONASH UNIVERSITY
MONASH
University
COUNTRIES WITH LIVE PATENTS AND PATENT APPLICATIONS
TOTAL PATENTS: 45
15 GRANTED
20
YEARS
FROM FILING
MONOPOLY PROVIDED
BY A PATENT
4DMedical™
FORMERLY 4DView entire presentation